Cleveland Clinic just brought in Joseph Elegante to lead their public equities investments—a move that could really shake things up for the hospital’s financial future. With years of experience managing big portfolios at UBS and other firms, Elegante is expected to bring fresh strategies and strong connections to the table. The Clinic’s investment office is also on the hunt for a new analyst to join his team. Given how much public equities have impacted returns (and risk!) lately, it’ll be interesting to see how this new leadership shapes the next decade. What do you think about this direction? #Business #ClevelandClinic #Investing